Situation: A nurse at the gynecology outpatient clinic of a provincial hospital cares for adult women with menstrual and menopausal problems. A 61-year-old woman whose last period was 9 years ago reports two episodes of vaginal spotting this month. She takes no hormone therapy. Transvaginal ultrasound shows an endometrial thickness of 7 mm. How should the nurse interpret this finding?

Postmenopausal bleeding must be evaluated for endometrial cancer. In a postmenopausal woman, an endometrial thickness of 4 mm or less is reassuring; a thicker lining, or persistent bleeding, calls for endometrial biopsy. Ultrasound measures thickness but cannot diagnose cancer or a polyp by itself.

Clinical interpretation

A postmenopausal woman with new vaginal spotting and an endometrial thickness of 7 mm on transvaginal ultrasound has a finding that requires tissue diagnosis. In postmenopausal women, the endometrial lining is expected to be thin because estrogen levels are low and the endometrium is atrophic. A double-layer endometrial thickness of 4 mm or less is generally considered reassuring in the setting of postmenopausal bleeding ^[3][4]. When the lining measures greater than 4 mm, or when bleeding persists regardless of thickness, endometrial sampling is indicated to exclude endometrial hyperplasia or carcinoma ^[1][3].

Transvaginal ultrasound can measure endometrial thickness, but it cannot distinguish benign atrophy, a polyp, hyperplasia, or endometrial cancer. The finding of a thickened endometrium in a woman with postmenopausal bleeding therefore triggers further evaluation with endometrial biopsy rather than observation or repeat imaging alone. This is the central clinical reasoning point for this scenario.

Watch out! The 4 mm threshold applies to the evaluation of postmenopausal bleeding. For asymptomatic postmenopausal women with incidental endometrial thickening, guidelines emphasize selective investigation to avoid unnecessary invasive procedures, because the risk of cancer is lower in the absence of bleeding ^[1]. However, this patient is symptomatic — she has had two episodes of spotting — so the bleeding itself is an independent indication for sampling.

Key point! Endometrial thickness is a screening measurement, not a diagnostic test. A thickened lining raises suspicion for endometrial pathology, but only histologic examination of tissue obtained by biopsy can confirm or exclude malignancy. Ultrasound findings such as 7 mm do not by themselves establish a diagnosis of endometrial cancer, nor do they confirm a benign polyp ^[1][2].

The rationale for the correct answer can be summarized by comparing the clinical implications of each option:

Interpretation	Why it is correct or incorrect
Endometrial sampling needed	Correct. Postmenopausal bleeding plus endometrial thickness greater than 4 mm warrants biopsy to rule out malignancy [3][4].
Atrophy likely, normal range	Incorrect. A thickness of 7 mm exceeds the expected atrophic range; atrophy typically produces a lining of 4 mm or less [3].
Confirms cancer, staging next	Incorrect. Ultrasound cannot diagnose cancer; histologic confirmation is required before staging [1][2].
Benign polyp, repeat scan in a year	Incorrect. Ultrasound cannot reliably identify a polyp as the cause, and delaying evaluation in a symptomatic postmenopausal woman risks missing malignancy [1][3].

Recent evidence reinforces that some endometrial cancer subtypes, particularly non-endometrioid histologies, may present with thinner endometrial measurements, and incomplete visualization of the endometrium can also limit ultrasound reliability ^[2][3]. This does not lower the threshold for biopsy in this case; rather, it underscores that ultrasound alone is insufficient to exclude cancer in a symptomatic postmenopausal woman. The combination of postmenopausal bleeding and a thickened endometrium is a high-priority indication for endometrial tissue sampling.